Drugs for parasitic infections.
D000563:Amebicides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000871:Anthelmintics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010272:Parasitic Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000563:Amebicides; D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000962:Antimalarials; D000981:Antiprotozoal Agents